loading
Schlusskurs vom Vortag:
$59.77
Offen:
$59.77
24-Stunden-Volumen:
229.57K
Relative Volume:
0.14
Marktkapitalisierung:
$2.33B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.42M
KGV:
-23.42
EPS:
-2.5513
Netto-Cashflow:
$-50.87M
1W Leistung:
+0.05%
1M Leistung:
+0.73%
6M Leistung:
+193.00%
1J Leistung:
+1,340%
1-Tages-Spanne:
Value
$59.76
$59.80
1-Wochen-Bereich:
Value
$59.47
$59.85
52-Wochen-Spanne:
Value
$3.60
$59.95

Longboard Pharmaceuticals Inc Stock (LBPH) Company Profile

Name
Firmenname
Longboard Pharmaceuticals Inc
Name
Telefon
619-592-9775
Name
Adresse
4275 EXECUTIVE SQUARE, LA JOLLA
Name
Mitarbeiter
33
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
LBPH's Discussions on Twitter

Vergleichen Sie LBPH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
LBPH 59.76 2.33B 0 -54.42M -50.87M -2.5513
VRTX 447.00 115.74B 10.63B -479.80M -1.35B 13.33
REGN 739.78 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.30 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.57 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.41 24.49B 3.30B -501.07M 1.03B 11.54

Longboard Pharmaceuticals Inc Stock (LBPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-10-24 Fortgesetzt Cantor Fitzgerald Overweight
2023-04-27 Eingeleitet B. Riley Securities Buy
2021-04-07 Eingeleitet Evercore ISI Outperform
2021-04-06 Eingeleitet Cantor Fitzgerald Overweight
2021-04-06 Eingeleitet Citigroup Buy
2021-04-06 Eingeleitet Guggenheim Buy
Alle ansehen

Longboard Pharmaceuticals Inc Aktie (LBPH) Neueste Nachrichten

pulisher
Nov 20, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MARX, BRKH, MNTX and LPBH - GlobeNewswire Inc.

Nov 20, 2024
pulisher
Nov 20, 2024

Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

299,156 Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Bought by Braun Stacey Associates Inc. - MarketBeat

Nov 18, 2024
pulisher
Nov 12, 2024

LBPHLongboard Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Longboard Pharmaceuticals Initiates Phase 3 DEEp Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Longboard Pharma Launches Groundbreaking Phase 3 Trial for Rare Epilepsy Treatment | LBPH Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 08, 2024

Longboard Pharmaceuticals Advances Neurological Treatments - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace

Nov 07, 2024
pulisher
Nov 07, 2024

Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

FMR LLC Reduces Stake in Longboard Pharmaceuticals Inc - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Longboard Pharma Reports Strong Q3, Advances Phase 3 Trial Amid Lundbeck Acquisition Deal | LBPH Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

How the (LBPH) price action is used to our Advantage - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com

Nov 05, 2024
pulisher
Nov 03, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year High – Here’s What Happened - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.95 By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

500: Something went wrong - Investing.com

Nov 01, 2024
pulisher
Oct 31, 2024

Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc.LBPH - Business Wire

Oct 31, 2024
pulisher
Oct 28, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of “Hold” by Analysts - Defense World

Oct 28, 2024
pulisher
Oct 27, 2024

Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN

Oct 27, 2024
pulisher
Oct 26, 2024

(LBPH) Trading Signals - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 25, 2024

B. Riley Offloads Great American To Oaktree To Cut Debt - Finimize

Oct 25, 2024
pulisher
Oct 23, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.48 By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year HighStill a Buy? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.48 - Investing.com India

Oct 23, 2024
pulisher
Oct 22, 2024

$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds

Oct 22, 2024
pulisher
Oct 21, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Oct 21, 2024
pulisher
Oct 20, 2024

The week in pharma: action, reaction and insight – week to October 19 | Pharmaceutical | The Pharmaletter - The Pharma Letter

Oct 20, 2024
pulisher
Oct 20, 2024

Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company - MSN

Oct 20, 2024
pulisher
Oct 19, 2024

Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion. - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

Longboard soars as Lundbeck to buy company for equity value of $2.6B - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

SG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - MSN

Oct 18, 2024
pulisher
Oct 18, 2024

Taxation With Representation: Baker, Simpson, Ropes - Law360

Oct 18, 2024
pulisher
Oct 18, 2024

Pα+ Psychedelic Bulletin #177: Bright Minds Surges on Longboard’s Seizure Drug Success; Kasvu Therapeutics Is Developing Psychoplastogens With a TrkB Twist - Psychedelic Alpha

Oct 18, 2024
pulisher
Oct 17, 2024

HC Wainwright Reiterates Neutral Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - Defense World

Oct 17, 2024
pulisher
Oct 17, 2024

Longboard Pharmaceuticals CMO sells $983,936 in stock By Investing.com - Investing.com South Africa

Oct 17, 2024
pulisher
Oct 16, 2024

Randall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Stock - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Malaysian Reserve

Oct 16, 2024
pulisher
Oct 16, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Lowered to Hold at Wedbush - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52% - MSN

Oct 16, 2024
pulisher
Oct 16, 2024

Lundbeck's billion-dollar acquisition will cost layoffs - MedWatch

Oct 16, 2024
pulisher
Oct 16, 2024

Lundbeck to Acquire Longboard Pharmaceuticals - CHEManager

Oct 16, 2024
pulisher
Oct 15, 2024

Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals - Global Legal Chronicle

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Lundbeck picks up Longboard Pharmaceuticals for $2.6B - MM+M Online

Oct 15, 2024

Finanzdaten der Longboard Pharmaceuticals Inc-Aktie (LBPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Longboard Pharmaceuticals Inc-Aktie (LBPH) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Lind Kevin Robert
CEO
Nov 13 '24
Option Exercise
3.12
12,808
40,002
443,740
Kaye Randall
CMO
Oct 15 '24
Option Exercise
4.35
16,667
72,501
34,587
Kaye Randall
CMO
Oct 15 '24
Sale
59.03
16,667
983,936
17,920
Kaye Randall
CMO
Sep 16 '24
Option Exercise
4.35
16,666
72,497
34,586
Kaye Randall
CMO
Sep 16 '24
Sale
31.64
16,666
527,318
17,920
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):